ArticleJACC. Case reports2025
Integrated Multimodal Imaging for Transvenous Transpulmonary Atrial Pacing Lead Implantation in Fontan Patient.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPacemaker placement in Fontan patients is challenging owing to lack of venous continuity with the atrial and ventricular myocardium. The standard epicardial approach is complicated by the need for repeat sternotomy or thoracotomy as well as the overall long-term risk of lead failure. Transvenous lead implant has been described, but this requires transpulmonary or transbaffle puncture, which have risks of bleeding and pericardial effusion. CASE SUMMARY: We describe a case in which multimodal imaging with fluoroscopy, computed tomography, intracardiac echocardiography, and three-dimensional electroanatomical mapping were combined to perform successful transvenous transpulmonary epicardial atrial lead placement in an extracardiac Fontan patient with protein-losing enteropathy. DISCUSSION: This approach can be considered as an alternative to epicardial lead placement in Fontan patients who are at moderate to high risk with the standard epicardial approach. TAKE-HOME MESSAGES: Congenital heart patients with extracardiac Fontan repairs pose unique technical challenges to pacemaker implantation given the lack of venous continuity with the myocardium. The transvenous, transpulmonary approach to epicardial atrial lead placement can be considered in high-risk extracardiac Fontan patients, using integrated multimodal imaging techniques to maximize safety and success.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.